Immune-derived data, particularly the characterization of the tumor microenvironment (TME) and peripheral immune cell populations (e.g., circulating PD-1+ CD4+ effector memory T cells), have emerged as independent predictors of progression-free survival and response to ICIs [112,113]. Here, CD4 is linked to neoplasm.